Trung Huynh | BiotechTV

top of page

RBC Global Healthcare Conference: US Large Cap Pharma Analyst Trung Huynh shares his take on the obesity market and rates Pfizer's last two major acquisitions

He discusses Lilly (his top pick) and the launch of Foundayo, and shares how he thinks about Pfizer's last two large acquisitions for Metsera and Seagen.

Bright Minds

11 hours ago

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page

RBC Global Healthcare Conference: US Large Cap Pharma Analyst Trung Huynh shares his take on the obesity market and rates Pfizer's last two major acquisitions

Follow BiotechTV

Sponsors

Sponsor Spotlight